4 July 2023:Croda International Plc (‘Croda’) today confirms that, following receipt of unconditional approval from the South Korean regulatory authorities, it has now successfully completed the acquisition of Solus Biotech, a global leader in premium, biotechnology-derived active ingredients f...
19 May 2023:Croda International Plc (Croda) today announced that it has signed two new partnership agreements that will help the pharmaceutical industry move towards a more sustainable supply chain for vaccine adjuvants. The first partnership is an exclusive license agreement with Amyris, a leading ...
Croda Foundation is the independently managed philanthropic arm of Croda International, established to benefit organisations, projects and communities globally, using Smart science to improve lives™. The Foundation’s trustees make the decisions on grant allocations linked to its charitable purposes. The...
Date:Jun. 2, 2022 Croda International Plc, the company that uses smart science to create high performance ingredients and solutions that improve lives, has been announced the win... 123NextLast # Business Magazine # 2024 Formulation & Adjuvant Technology Sponsor: Language: English Publication Date...
News Snippet Sources 3/20/2024 Licensor Access to Advanced Health Institute United States Croda and AAHI enter vaccine adjuvant formulations partnership Under the partnership , Croda International will gain specific rights for the marketing , distribution , and sale of selected new adjuvant formulations...
Find out more Environmental, Social and Governance (ESG) Useful links to further information on our environmental, governance and social impact. Find out more Regulatory news Our most recent announcements to the stock exchange. Find out more ...